Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair

Jithma P. Abeykoon, Xiaosheng Wu, Kevin E. Nowakowski, Surendra Dasari, Jonas Paludo, S. John Weroha, Chunling Hu, Xiaonan Hou, Jann N. Sarkaria, Ann C. Mladek, Jessica L. Phillips, Andrew L. Feldman, Aishwarya Ravindran, Rebecca L. King, Justin Boysen, Mary J. Stenson, Ryan M. Carr, Michelle K. Manske, Julian R. Molina, Prashant KapoorSameer A. Parikh, Shaji Kumar, Steven I. Robinson, Jia Yu, Judy C. Boughey, Liewei Wang, Matthew P. Goetz, Fergus J. Couch, Mrinal M. Patnaik, Thomas E. Witzig

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds